Group 1 - The second China Pharmaceutical Health Industry Development Conference highlighted the innovative capabilities of Zibo's pharmaceutical sector, showcasing a complete chain from research and development to clinical application [1] - The event featured a visit to Shandong Shibo Jindu Pharmaceutical, where representatives observed modern drug production lines and quality control systems, emphasizing the transition from laboratory innovations to practical medical solutions [1] - A notable innovation presented was the "Liwei Wuling Pian," a drug addressing liver damage, which signifies Zibo's advancements in pharmaceutical innovation [1] Group 2 - The conference included a public health initiative, "Experts Going to the Grassroots," where specialists from various medical fields provided free consultations, demonstrating a commitment to community health and the "Healthy China" strategy [2] - The event facilitated one-on-one consultations for chronic disease management, cancer prevention, and traditional Chinese medicine, reflecting a holistic approach to patient care [2] - The collaboration between academic events and grassroots health services underscores the importance of accessible healthcare and the responsibility of medical professionals to engage with the community [2]